aXichem AB (AXIC-A) - Total Assets
Based on the latest financial reports, aXichem AB (AXIC-A) holds total assets worth Skr67.76 Million SEK (≈ $7.29 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See aXichem AB shareholders equity for net asset value and shareholders' equity analysis.
aXichem AB - Total Assets Trend (2008–2024)
This chart illustrates how aXichem AB's total assets have evolved over time, based on quarterly financial data.
aXichem AB - Asset Composition Analysis
Current Asset Composition (December 2024)
aXichem AB's total assets of Skr67.76 Million consist of 37.8% current assets and 62.2% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 19.3% |
| Accounts Receivable | Skr5.95 Million | 8.0% |
| Inventory | Skr7.76 Million | 10.5% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr46.20 Million | 62.2% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how aXichem AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see AXIC-A company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: aXichem AB's current assets represent 37.8% of total assets in 2024, an increase from 1.2% in 2008.
- Cash Position: Cash and equivalents constituted 19.3% of total assets in 2024, up from 1.0% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is intangible assets at 62.2% of total assets.
aXichem AB Competitors by Total Assets
Key competitors of aXichem AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Givaudan SA
F:GIN1
|
Germany | €11.86 Billion |
|
EVONIK INDUST.(U.ARD)2
F:EVKA
|
Germany | €17.98 Billion |
|
Huaibei Mining Holdings Co Ltd
SHG:600985
|
China | CN¥89.26 Billion |
|
Shandong Dongyue Organosilicon Mat
SHE:300821
|
China | CN¥6.07 Billion |
|
Fujian Kuncai Material Tech
SHG:603826
|
China | CN¥4.98 Billion |
|
Dalian Bio-Chem Co Ltd
SHG:603360
|
China | CN¥3.99 Billion |
|
Aarti Industries Limited
NSE:AARTIIND
|
India | Rs132.99 Billion |
|
Shenzhen Cotran New Material Co Ltd Class A
SHE:300731
|
China | CN¥1.34 Billion |
aXichem AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.17 | 2.95 | 6.85 |
| Quick Ratio | 1.05 | 1.90 | 6.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr11.30 Million | Skr14.23 Million | Skr12.28 Million |
aXichem AB - Advanced Valuation Insights
This section examines the relationship between aXichem AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.44 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 20.8% |
| Total Assets | Skr74.28 Million |
| Market Capitalization | $9.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values aXichem AB's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: aXichem AB's assets grew by 20.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for aXichem AB (2008–2024)
The table below shows the annual total assets of aXichem AB from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr74.28 Million ≈ $7.99 Million |
+20.81% |
| 2023-12-31 | Skr61.49 Million ≈ $6.62 Million |
+0.39% |
| 2022-12-31 | Skr61.25 Million ≈ $6.59 Million |
+4.22% |
| 2021-12-31 | Skr58.77 Million ≈ $6.32 Million |
+5.43% |
| 2020-12-31 | Skr55.75 Million ≈ $6.00 Million |
-19.17% |
| 2019-12-31 | Skr68.97 Million ≈ $7.42 Million |
+79.43% |
| 2018-12-31 | Skr38.44 Million ≈ $4.14 Million |
-0.31% |
| 2017-12-31 | Skr38.56 Million ≈ $4.15 Million |
-17.97% |
| 2016-12-31 | Skr47.01 Million ≈ $5.06 Million |
+52.26% |
| 2015-12-31 | Skr30.87 Million ≈ $3.32 Million |
+21.67% |
| 2014-12-31 | Skr25.38 Million ≈ $2.73 Million |
-35.14% |
| 2013-12-31 | Skr39.13 Million ≈ $4.21 Million |
+125.41% |
| 2012-12-31 | Skr17.36 Million ≈ $1.87 Million |
-22.89% |
| 2011-12-31 | Skr22.51 Million ≈ $2.42 Million |
+52.72% |
| 2010-12-31 | Skr14.74 Million ≈ $1.59 Million |
+11.07% |
| 2009-12-31 | Skr13.27 Million ≈ $1.43 Million |
-16.36% |
| 2008-12-31 | Skr15.87 Million ≈ $1.71 Million |
-- |
About aXichem AB
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings a… Read more